DE

Joerg Kaufmann

This inventor holds 0 USPTO granted patents, plus 3 CIPO patents.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joerg Kaufmann. Retrieved from https://idiyas.com/inventor/joerg-kaufmann-u15hifr1

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Joerg Kaufmann: Innovator in RNA Technology

Introduction

Joerg Kaufmann is a notable inventor based in Germany, recognized for his contributions to the field of ribonucleic acid (RNA) technology. With a focus on innovative solutions, he has developed several significant inventions that aim to advance scientific understanding and applications in molecular biology.

Latest Patents

Kaufmann's latest patents include "Modified Forms Of Interfering RNA Molecules," which relates to a ribonucleic acid comprising a double-stranded structure. This structure includes a first strand that is at least partially complementary to a target nucleic acid and a second strand that is at least partially identical to a target nucleic acid. The double-stranded structure is designed to be blunt-ended. Another notable invention is "Coated Lipid Complexes And Their Use," which involves a lipid composition that includes a first lipid component, a first helper lipid, and a removable shielding compound that can be detached under in vivo conditions.

Career Highlights

Throughout his career, Joerg Kaufmann has worked with prominent companies in the biotechnology sector, including Silence Therapeutics GmbH and Quark Pharmaceuticals, Inc. His work in these organizations has contributed to the development of innovative therapeutic solutions.

Collaborations

Kaufmann has collaborated with esteemed colleagues such as Klaus Giese and Anke Klippel-Giese, further enhancing his research and development efforts in the field of RNA technology.

Conclusion

Joerg Kaufmann's work exemplifies the innovative spirit in the biotechnology industry. His contributions to RNA technology and collaborations with leading professionals highlight his commitment to advancing scientific knowledge and applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…